The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Activated Carbon Market Research Report 2025

Global Pharmaceutical Activated Carbon Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1902709

No of Pages : 78

Synopsis
The global Pharmaceutical Activated Carbon market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.
Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.
The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Activated Carbon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Activated Carbon.
Report Scope
The Pharmaceutical Activated Carbon market size, estimations, and forecasts are provided in terms of output/shipments (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Activated Carbon market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Activated Carbon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.
Market Segmentation
By Company
Jemincare
Changtian Pharma
Kureha
Myvitamins
Segment by Type
Pharmaceutical Activated Carbon Capsule
Pharmaceutical Activated Carbon Tablet
Others
Segment by Distribution Channel
Drug Stores
Prescription Drug
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Distribution Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Activated Carbon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Activated Carbon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Activated Carbon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index
1 Pharmaceutical Activated Carbon Market Overview
1.1 Product Definition
1.2 Pharmaceutical Activated Carbon Segment by Type
1.2.1 Global Pharmaceutical Activated Carbon Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Pharmaceutical Activated Carbon Capsule
1.2.3 Pharmaceutical Activated Carbon Tablet
1.2.4 Others
1.3 Pharmaceutical Activated Carbon Segment by Distribution Channel
1.3.1 Global Pharmaceutical Activated Carbon Market Value Growth Rate Analysis by Distribution Channel: 2023 VS 2030
1.3.2 Drug Stores
1.3.3 Prescription Drug
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Pharmaceutical Activated Carbon Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Pharmaceutical Activated Carbon Production Estimates and Forecasts (2019-2030)
1.4.4 Global Pharmaceutical Activated Carbon Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Activated Carbon Production Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Activated Carbon Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Pharmaceutical Activated Carbon, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Pharmaceutical Activated Carbon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Pharmaceutical Activated Carbon Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Pharmaceutical Activated Carbon, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Activated Carbon, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Activated Carbon, Date of Enter into This Industry
2.9 Pharmaceutical Activated Carbon Market Competitive Situation and Trends
2.9.1 Pharmaceutical Activated Carbon Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Activated Carbon Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Activated Carbon Production by Region
3.1 Global Pharmaceutical Activated Carbon Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Pharmaceutical Activated Carbon Production Value by Region (2019-2030)
3.2.1 Global Pharmaceutical Activated Carbon Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Pharmaceutical Activated Carbon by Region (2025-2030)
3.3 Global Pharmaceutical Activated Carbon Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Pharmaceutical Activated Carbon Production by Region (2019-2030)
3.4.1 Global Pharmaceutical Activated Carbon Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Pharmaceutical Activated Carbon by Region (2025-2030)
3.5 Global Pharmaceutical Activated Carbon Market Price Analysis by Region (2019-2024)
3.6 Global Pharmaceutical Activated Carbon Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Pharmaceutical Activated Carbon Production Value Estimates and Forecasts (2019-2030)
4 Pharmaceutical Activated Carbon Consumption by Region
4.1 Global Pharmaceutical Activated Carbon Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Pharmaceutical Activated Carbon Consumption by Region (2019-2030)
4.2.1 Global Pharmaceutical Activated Carbon Consumption by Region (2019-2024)
4.2.2 Global Pharmaceutical Activated Carbon Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Pharmaceutical Activated Carbon Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Pharmaceutical Activated Carbon Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Activated Carbon Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Pharmaceutical Activated Carbon Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Pharmaceutical Activated Carbon Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Pharmaceutical Activated Carbon Production by Type (2019-2030)
5.1.1 Global Pharmaceutical Activated Carbon Production by Type (2019-2024)
5.1.2 Global Pharmaceutical Activated Carbon Production by Type (2025-2030)
5.1.3 Global Pharmaceutical Activated Carbon Production Market Share by Type (2019-2030)
5.2 Global Pharmaceutical Activated Carbon Production Value by Type (2019-2030)
5.2.1 Global Pharmaceutical Activated Carbon Production Value by Type (2019-2024)
5.2.2 Global Pharmaceutical Activated Carbon Production Value by Type (2025-2030)
5.2.3 Global Pharmaceutical Activated Carbon Production Value Market Share by Type (2019-2030)
5.3 Global Pharmaceutical Activated Carbon Price by Type (2019-2030)
6 Segment by Distribution Channel
6.1 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2019-2030)
6.1.1 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2019-2024)
6.1.2 Global Pharmaceutical Activated Carbon Production by Distribution Channel (2025-2030)
6.1.3 Global Pharmaceutical Activated Carbon Production Market Share by Distribution Channel (2019-2030)
6.2 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2019-2030)
6.2.1 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2019-2024)
6.2.2 Global Pharmaceutical Activated Carbon Production Value by Distribution Channel (2025-2030)
6.2.3 Global Pharmaceutical Activated Carbon Production Value Market Share by Distribution Channel (2019-2030)
6.3 Global Pharmaceutical Activated Carbon Price by Distribution Channel (2019-2030)
7 Key Companies Profiled
7.1 Jemincare
7.1.1 Jemincare Pharmaceutical Activated Carbon Corporation Information
7.1.2 Jemincare Pharmaceutical Activated Carbon Product Portfolio
7.1.3 Jemincare Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Jemincare Main Business and Markets Served
7.1.5 Jemincare Recent Developments/Updates
7.2 Changtian Pharma
7.2.1 Changtian Pharma Pharmaceutical Activated Carbon Corporation Information
7.2.2 Changtian Pharma Pharmaceutical Activated Carbon Product Portfolio
7.2.3 Changtian Pharma Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Changtian Pharma Main Business and Markets Served
7.2.5 Changtian Pharma Recent Developments/Updates
7.3 Kureha
7.3.1 Kureha Pharmaceutical Activated Carbon Corporation Information
7.3.2 Kureha Pharmaceutical Activated Carbon Product Portfolio
7.3.3 Kureha Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Kureha Main Business and Markets Served
7.3.5 Kureha Recent Developments/Updates
7.4 Myvitamins
7.4.1 Myvitamins Pharmaceutical Activated Carbon Corporation Information
7.4.2 Myvitamins Pharmaceutical Activated Carbon Product Portfolio
7.4.3 Myvitamins Pharmaceutical Activated Carbon Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Myvitamins Main Business and Markets Served
7.4.5 Myvitamins Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Activated Carbon Industry Chain Analysis
8.2 Pharmaceutical Activated Carbon Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Activated Carbon Production Mode & Process
8.4 Pharmaceutical Activated Carbon Sales and Marketing
8.4.1 Pharmaceutical Activated Carbon Sales Channels
8.4.2 Pharmaceutical Activated Carbon Distributors
8.5 Pharmaceutical Activated Carbon Customers
9 Pharmaceutical Activated Carbon Market Dynamics
9.1 Pharmaceutical Activated Carbon Industry Trends
9.2 Pharmaceutical Activated Carbon Market Drivers
9.3 Pharmaceutical Activated Carbon Market Challenges
9.4 Pharmaceutical Activated Carbon Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’